Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14218/JCTH.2020.00061 http://scihub22266oqcxt.onion/10.14218/JCTH.2020.00061 33447532!7782113!33447532     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Transl+Hepatol 2020 ; 8 (4): 467-473 Nephropedia Template TP {{tp|p=33447532|t=2020. COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery |pdf=|usr=}}{{33447532}} gab.com Text COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery JO: J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=33447532 #FOAvip The severe acute respiratory syndrome corona virus-2 (referred to as SARS CoV2) pandemic had a great impact on public life in general as well as on populations with pre-existing disease and co-morbidities. Liver transplant and immunosuppressant medication predisposes to more severe disease and is often associated with poor outcome. The clinical features, disease course, treatment and process of modulating the immunosuppression is challenging. Here, we describe the clinical presentation, treatment and outcomes in six liver transplant recipients. Out of those six patients, three had mild, one had moderate and one had severe COVID-19, and one was asymptomatic. The immunosuppression minimization or withdrawal was done based upon the clinical severity. Consideration of tocilizumab and/o convalescent plasma as well as antivirals i.e. remdesvir done in severe cases. The routine practice of prophylactic anticoagulation, consideration of repurposed drugs (i.e. teicoplanin and doxycycline), and watchful monitoring of asymptomatic recipients helped to achieve an uneventful recovery. Twit Text FOAVip COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery ????J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=33447532 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33447532 #FOAvip English Wikipedia <ref>{{Cite pmid|33447532}}</ref> COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery #MMPMID33447532 Choudhury A; Reddy GS; Venishetty S; Pamecha V; Shasthry SM; Tomar A; Mitra LG; Prasad VST; Mathur RP; Bhattacharya D; Sarin SK J Clin Transl Hepatol 2020[Dec]; 8 (4): 467-473 PMID33447532show ga The severe acute respiratory syndrome corona virus-2 (referred to as SARS CoV2) pandemic had a great impact on public life in general as well as on populations with pre-existing disease and co-morbidities. Liver transplant and immunosuppressant medication predisposes to more severe disease and is often associated with poor outcome. The clinical features, disease course, treatment and process of modulating the immunosuppression is challenging. Here, we describe the clinical presentation, treatment and outcomes in six liver transplant recipients. Out of those six patients, three had mild, one had moderate and one had severe COVID-19, and one was asymptomatic. The immunosuppression minimization or withdrawal was done based upon the clinical severity. Consideration of tocilizumab and/o convalescent plasma as well as antivirals i.e. remdesvir done in severe cases. The routine practice of prophylactic anticoagulation, consideration of repurposed drugs (i.e. teicoplanin and doxycycline), and watchful monitoring of asymptomatic recipients helped to achieve an uneventful recovery. äCOVID-19 in Liver Transplant Recipients - A Series with Successful Rec(epmc).pdf DeepDyve Pubget Overpricing